Leaders in Supply & Demand Side Intelligence

Forgot your login?

[X]

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.

E-Mail:
Also, what is 45 + 9?

Key Players in China's CDMO Pharma-Bio Market Push Forward

Premium Article

BEIJING--June 11, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Key players in the Chinese contract development and manufacturing organization (CDMO) market such as Wuxi AppTec & Wuxi Biologics, Asymchem Laboratories (Tianjin) Co., Ltd., Porton Pharma Solutions Ltd., Apeloa Pharmaceutical Co., Ltd and Zhejiang Jiuzhou Pharmaceutical Co. Ltd, among others, have employed various strategies to expand their product and application offerings and global footprint, and augment their market share.

Read the Complete Article
Details on this Article:
Industry Segment: Pharmaceutical & Biotech
Word Count: 294 Words
Listen to Today's News News Audio Library Sync News Podcasts

Login or Register now for instant access!
Related Articles
Premium News Article
  China's Pharmaceutical Companies Turn Attention to Monoclonal Antibodies
Premium News Article
  China Authorizes Five Companies to Make COVID-19 Vaccines
Premium News Article
  China's Pharma Companies Face Fiscal Challenges for R&D Projects
Premium News Article
  Real Estate Developers Pour $34 Billion into Global Life Science Building D...
Premium News Article
  China's Pharma Market Could See New Growth Wave as India's Plants Close

PREMIUM ARTICLE

This article is available for Premium Members only.

Subscribe Now! All Fields are Required...


Pricing Help?

All Members Receive the Following Resources:

  • Industry News Digest
  • Upcoming Webinars
  • On-Demand Webinars
  • The NavigatIIR Newsletter
  • Daily Industry News Blog
  • Economic Indicators